Parx Materials N.V.
Parx Materials NV is a materials innovation company specializing in the development and manufacturing of sustainable, biocompatible materials with intrinsic antimicrobial, antiviral, and anti-fungal properties. Their technology, inspired by the human immune system, uses a natural trace element to prevent microbial adhesion and proliferation without the use of harmful chemicals, biocides, or nanoparticles. Recognized for its effectiveness and safety, the company's solutions are applicable in food packaging, medical devices, textiles, pipes, and other industries, contributing to improved hygiene, longer shelf life, and environmental sustainability.
Industries
Nr. of Employees
small (1-50)
Parx Materials N.V.
Vijverhofstraat 47, 3032 SB Rotterdam, The Netherlands
Products
Antimicrobial polymer additive (granules)
Granule-form additive intended for homogeneous blending into thermoplastic resins to impart persistent, non-leaching resistance to microbial adhesion, biofilm and fouling while maintaining compatibility with standard polymer processing.
Antimicrobial polymer additive (granules)
Granule-form additive intended for homogeneous blending into thermoplastic resins to impart persistent, non-leaching resistance to microbial adhesion, biofilm and fouling while maintaining compatibility with standard polymer processing.
Services
Advisory and hands-on support to optimize blending and processing parameters for incorporating antimicrobial additive granules into customer polymer formulations and production lines.
Support to obtain independent laboratory verification of antimicrobial, antiviral and durability performance according to international standards through coordination with accredited labs.
Assessment of formulation substances against applicable EU and US food-contact regulations and related inventories, and preparation of supporting safety documentation based on regulatory databases and standards.
Advisory and hands-on support to optimize blending and processing parameters for incorporating antimicrobial additive granules into customer polymer formulations and production lines.
Support to obtain independent laboratory verification of antimicrobial, antiviral and durability performance according to international standards through coordination with accredited labs.
Assessment of formulation substances against applicable EU and US food-contact regulations and related inventories, and preparation of supporting safety documentation based on regulatory databases and standards.
Expertise Areas
- Antimicrobial materials for polymers
- Food-contact material safety and compliance assessment
- Medical device material biocompatibility and pre-clinical evaluation
- Anti-biofilm and anti-fouling material solutions
Key Technologies
- Polymer compounding and granule dosing
- Biomimetic surface engineering
- Ionic trace element incorporation in polymers
- Injection molding, extrusion and blow-molding integration
News & Updates
The company announced its AGM scheduled for June 27, 2025, in Rotterdam, Netherlands.
Parx Materials acquired its first machine for a new production setup in Italy to scale up capacity.
New management nominations were appointed during the October 23, 2024, meeting.
A strategic move to expand and implement Parx's groundbreaking technology.
A study shows significant infection reduction using their antimicrobial materials in hernia mesh.
87% efficacy against super-resistant Candida auris fungus within 24 hours.
The company announced its AGM scheduled for June 27, 2025, in Rotterdam, Netherlands.
Parx Materials acquired its first machine for a new production setup in Italy to scale up capacity.
New management nominations were appointed during the October 23, 2024, meeting.
A strategic move to expand and implement Parx's groundbreaking technology.
A study shows significant infection reduction using their antimicrobial materials in hernia mesh.
87% efficacy against super-resistant Candida auris fungus within 24 hours.